References
- Clozel M, Gray G. A., Breu V., Loffler B.-M., Oster-Walder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophys. Res. Comm. 1992; 186: 867–873
- D'Orléans-Juste P., Télémaque S., Claing A. Different pharmacological profiles of big-endothelin-3 and big-endo-thelin-1 in vivo and in vitro. Br. Pharmacol. 1991; 104: 440–444
- Emori T., Hirata Y., Marumo F. Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett. 1990; 263: 261–264
- Gardiner S. M., Kemp P. A., Compton A. M., Bennett T. Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1–381] and proendothelin-3 [1–41] in conscious rats. Br. J. Pharmacol 1992; 106: 483–488
- Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1991; 50: 247–255
- Martin E. R., Brenner B. M., Ballermann B. J. Heterogeneity of cell surface endothelin receptors. J. Biol. Chem. 1990; 265: 14044–14049
- McMahon E. G., Palomo M. A., Moore W. M., McDonald J., Stern M. K. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1–39)in vivo and conversion of big endothelin-1-(1–3) to endothelin-1-(1–21) in vitro. Proc. Natl. Acad. Sci. USA 1991; 88: 703–707
- Moreland S., McMulIen D., Delaney C. L., Lee V. G., Hunt J. T. Vascular muscle contains vasoconstrictor ETB receptors (Abstract). J. Vase. Res. 1992; 29: 171
- Opgenorth T. J., Wu-Wong J. R., Shiosaki K. Endothelin converting enzymes. FASEB J. 1992; 6: 2653–2659
- Pollock D. M., Opgenorth T. J. a) Comparison of the hemodynamic effects of endothelin-1 and big endothelin-1 in the rat. Biochem. Biophys. Res. Comm. 1991; 179: 1122–1126
- Pollock D. M., Opgenorth T. J. Evidence for metalloprotease involvement in thein vivo effects of big endothelin-1. Am. J. Physiol. 1991b; 261: R257–R263
- Pollock D. M., Opgenorth T. J. Evidence for endothelin induced renal vasoconstriction independent of ETA receptor activation. Am. J. Physiol. 1993; 264: R222–R226
- Sakurai T., Yanagisawa M., Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 1992; 13: 103–108
- Simonson M. S., Dunn M. J. Cellular signalling by peptides of the endothelin gene family. FASEB J. 1990; 4: 2985–3000
- Takayanagi R., Kitazumi K., Takasaki C, Ohnaka K., Aimoto S., Tasaka K., Ohashi M., Nawata H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 1991; 282: 103–106
- Warner T. D., Mitchell J. A., de Nucci G., Vane J. R. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J. Cardiovasc. Pharmacol. 1989; 13: S85–S88, suppl. 5
- Woodcock E. A., Land S. Endothelin receptors in rat renal papilla with a high affinity for endothelin-3. Eur. J. Pharmacol. 1991; 208: 255–260
- Yamashita Y., Yukimura T., Miura K., Okumura M., Yamamoto K. Effects ofNG-nitro-L-arginine on renal hemodynamic responses to endothelin-3 in anesthetized dogs. J. Cardiovasc. Pharmacol. 1991; 17: S332–S334, suppl 7